Previous 10 | Next 10 |
2023-08-30 07:15:16 ET Serina Therapeutics on Wednesday said it would merge with a wholly-owned subsidiary of AgeX Therapeutics ( NYSE: AGE ) in an all-stock transaction. The combined company will focus on advancing Serina’s lead drug candidate (SER-252, ...
Merger to result in NYSE American-listed company focused on developing therapeutics based on Serina’s proprietary POZ Platform ™ delivery technology Lead program of the combined company will be SER-252 (POZ-apomorphine) for the treatment of advanced Parkinson’...
2023-08-14 17:15:37 ET AgeX Therapeutics press release ( NYSE: AGE ): Q2 GAAP EPS of -$0.07. Revenue of $0.09M (+800.0% Y/Y). For further details see: AgeX Therapeutics GAAP EPS of -$0.07, revenue of $0.09M
AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for the quarter and six months ended June 30, 2023. Balance Sheet Information Cash, cash e...
(NewsDirect) Alligator Energy Ltd (ASX:AGE) CEO Greg Hall tells Proactive that drilling operations at the Samphire Uranium Project continued during the June quarter with a second drill rig arriving onsite in May. Resource infill, resource extension and water sampling test drilling will extend...
2023-07-21 17:56:59 ET AgeX Therapeutics ( NYSE: AGE ) said Friday it entered into a shares-for-debt exchange agreement with Juvenescence Limited. The company agreed to issue to Juvenescence 211,600 shares of newly authorized Series A preferred stock and 148,400 shares o...
(NewsDirect) Alligator Energy Ltd (ASX:AGE) CEO Greg Hall tells Proactive the 2023 drilling program at Blackbush deposit within the Samphire Uranium Project in South Australia has had a great start intersecting more uranium mineralisation. The results are expected to support an increased conf...
AgeX Therapeutics , Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, announced today that on May 17, 2023 it received a notice from the staff of the NYSE American (the “Exchange”) indicating that the...
2023-05-12 16:27:15 ET AgeX Therapeutics press release ( NYSE: AGE ): Q1 GAAP EPS of -$0.09. Revenue of $0.01M. For further details see: AgeX Therapeutics GAAP EPS of -$0.09, revenue of $0.01M
AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for quarter ended March 31, 2023. Balance Sheet Information Cash, cash equivalents, and re...
News, Short Squeeze, Breakout and More Instantly...
Shares of Serina to commence trading on NYSE American under the ticker symbol “SER” on March 27, 2024 Lead candidate SER-252, POZ-apomorphine preclinical studies anticipated to be completed in the fourth quarter of 2024; IND submission to the FDA for the initiation of a Phas...
ALAMEDA, Calif., March 22, 2024 (GLOBE NEWSWIRE) -- AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for fourth quarter and the full year ended Decembe...
A look at the top 10 most actives in the United States Verb Technology Company Inc. (VERB) rose 211.4% to $0.4422 on volume of 532,901,553 shares Fisker Inc. Class A (FSR) rose 12.8% to $0.1747 on volume of 376,460,729 shares Better Therapeutics Inc. (BTTX) rose 27.4% to $0.0446 on volume...